LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Dentsply investigation page on our website at www.glancylaw.com/case/dentsply-sirona-inc.
On June 5, 2018, analysts at Northcoast’s equities division lowered Northcoast’s rating for Dentsply shares from “Buy” to “Neutral.” On this news, Dentsply’s share price fell $1.65, or 3.76%, to close at $42.29 per share on June 5, 2018, thereby injuring investors.
If you purchased Dentsply securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.